(2026). Dupilumab is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities. Journal of Asthma and Allergy.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"Dupilumab Is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities."
Journal of Asthma and Allergy 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"Dupilumab Is Effective in Young Children with Atopic Dermatitis Regardless of Type 2 Comorbidities."
Journal of Asthma and Allergy, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.